Journal of Enzyme Inhibition and Medicinal Chemistry · 2011 · 20 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyImmunoregulationInflammationStructure-activity RelationshipsAnti-inflammatory PharmacologyBioactive Small MoleculesImmunomodulatory DrugsReactive Oxygen SpeciesStructure-activity Relationship AnalysisCell Proliferation IndicesConcentrationImmunomodulatory EffectsOxidative Burst AssaysProinflammatory Cytokine ModulationProinflammatory Mediators
A series of S- and N-alkylated indolyloxadiazoles 2-7 were prepared. All compounds were tested for their immunomodulatory activity against T-cell proliferation, oxidative burst and cytokine analysis. Compounds 1, 2a, 2b, 2c and 2k demonstrated highly significant (P ≤ 0.005) inhibition on PHA activated T-cell proliferation with IC(50) less than 3 µg/mL concentration, while 3b exert a moderate inhibitory effect with IC(50) 8.6 µg/mL. Among all compounds of the series, only 2h was found to suppress phagocytes ROS production (IC(50) 2.4 µg/mL) in luminol-based chemiluminescence (CL) assay. Compounds 2a-k have stimulatory effect on proinflammatory cytokine predominantly IL-1β but no effect on IL-4 and NO production indicating that these compounds might have selective inhibitory effect on T-cell proliferation. Cytotoxic effect on T-cell proliferation was tested on NIH-3T3 mouse fibroblast normal cell line. All compounds were found to be free from toxic effects up to 100 μM concentration.
20
Shashikant V. Bhandari, Kailash G. Bothara, Mayuresh K. Raut et al. · Bioorganic & Medicinal Chemistry · 2007 · 301 citations
Stephen L. Helfand, J. A. Werkmeister, John Roder · The Journal of Experimental Medicine · 1982 · 199 citations · Full text